Co-founder, Chair of the SAB @ (April 2017 - Present)
Member, Scientific Advisory Board @ (January 2017 - May 2025)
Member, Scientific Advisory Board @ (May 2015 - July 2024)
Member, Scientific Advisory Board @ (January 2012 - January 2017)
Co-founder, SAB member @ (January 2009 - January 2015)
Associate Director @ (January 2008 - August 2017)
Associate Director @ (January 2008 - August 2017)
Co-founder, SAB Chair, Office of the CSO @ (April 2007 - April 2017)
C.P. Dubbs Professor @ (January 1999 - Present)
Cofounder @ BioDisplay (January 1998 - January 2001)
Professor @ (January 1989 - January 1999)
Postdoctoral Researcher @ (September 1988 - August 1989)
Karl Wittrup Education
Caltech
Ph.D. (Chemical Engineering)
1984-1988
The University of New Mexico
B.S. (Chemical Engineering)
1980-1984
Karl Wittrup Skills
Protein Chemistry
Drug Discovery
Clinical Research
Protein Engineering
Biopharmaceuticals
Molecular Biology
Protein Purification
Pharmacology
R&D
Antibodies
Cancer
Lifesciences
Biomarker Discovery
Science
Drug Delivery
Cell
Biotechnology
Protein Expression
Chemical Engineering
Immunology
Marketing
Data Analysis
Purification
Laboratory
Assay Development
Monoclonal Antibodies
Flow Cytometry
Drug Development
Biophysics
Strategy
Cell Biology
Biologics
Technology Transfer
ELISA
Biochemistry
Teaching
In Vitro
Karl Wittrup Summary
Karl Wittrup, based in Cambridge, MA, US, is currently a Co-founder, Cullinan Amber LLC at Cullinan Oncology. Karl Wittrup brings experience from previous roles at DEM Biopharma, Inc., 76Bio, Inc., Aktis Oncology and LAVA Therapeutics N.V.. Karl Wittrup holds a 1984 - 1988 Ph.D. in Chemical Engineering @ Caltech. With a robust skill set that includes Protein Chemistry, Drug Discovery, Clinical Research, Protein Engineering, Biopharmaceuticals and more. Karl Wittrup has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Karl Wittrup?
Find contact details for 700 million professionals.